Zepp Health Corporation
ZEPP
$37.96
$0.591.58%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 182.65M | 206.12M | 246.77M | 298.58M | 352.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 182.65M | 206.12M | 246.77M | 298.58M | 352.87M |
| Cost of Revenue | 112.40M | 128.96M | 158.68M | 206.53M | 260.51M |
| Gross Profit | 70.25M | 77.16M | 88.08M | 92.05M | 92.36M |
| SG&A Expenses | 71.31M | 68.58M | 66.09M | 68.62M | 71.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 229.84M | 243.74M | 270.47M | 322.80M | 383.30M |
| Operating Income | -47.18M | -37.62M | -23.70M | -24.22M | -30.44M |
| Income Before Tax | -62.04M | -37.21M | -23.62M | -24.54M | -33.51M |
| Income Tax Expenses | 13.69M | 2.89M | 2.96M | 1.26M | -2.43M |
| Earnings from Continuing Operations | -75.74 | -40.10 | -26.58 | -25.79 | -31.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 75.20K | 35.20K | 54.20K | 70.20K | 66.40K |
| Net Income | -75.66M | -40.07M | -26.52M | -25.72M | -31.01M |
| EBIT | -47.18M | -37.62M | -23.70M | -24.22M | -30.44M |
| EBITDA | -40.17M | -29.94M | -15.95M | -16.38M | -22.35M |
| EPS Basic | -74.98 | -39.64 | -26.20 | -26.10 | -32.47 |
| Normalized Basic EPS | -1.68 | -1.06 | -0.53 | -0.53 | -0.86 |
| EPS Diluted | -75.10 | -40.91 | -27.53 | -27.43 | -33.76 |
| Normalized Diluted EPS | -1.68 | -1.06 | -0.53 | -0.53 | -0.86 |
| Average Basic Shares Outstanding | 64.72M | 63.74M | 62.79M | 61.73M | 60.83M |
| Average Diluted Shares Outstanding | 4.04M | 3.98M | 3.97M | 3.91M | 3.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |